C ommunity-academic partnerships [1] [2] [3] [4] have begun to explore the burgeoning field of genomics research, par ticularly as it applies to diverse populations. 5, 6 It can be difficult to engage marginalized communities in genomics and precision medicine research, due both to familiar barriers to community engagement (e.g., mistrust) and more genomicspecific challenges (e.g., its highly technical language). 6, 7 Unfortunately, there is limited information available regarding formation of substantive collaborations to navigate the complex intersection of ancestry, race, genomics and health.
Variants of the Apolipoprotein L1 (APOL1) gene are linked to a 10-fold increased risk of kidney failure among adults with hypertension. 8 This is one of the first genetic variants linked to a significantly increased risk of a serious, common, chronic
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Community-based participatory research, community health partnerships, health disparities, community health research, urban health disease. Because the high-risk variants thrived to protect people from sleeping sickness, found only in the African conti nent, they occur almost exclusively in people of African ancestry
(1/7 of whom have high-risk variants). 9 In light of the prevalence, significance and ancestral history of these gene variants, the aforementioned barriers pose an important opportunity to further community engagement in research.
THE GUARDD COMMUNITY ACTION BOARD
In 2010, a genomics researcher approached a community-academic research partnership board, which advises a medical school's translational research enterprise, 10 
METHODS
Board members decided to collect and reflect on our experi ences. We asked a research coordinator with experience in qualitative research, who works outside the board, to attend our meetings and help us to tell our story. Using six questions regarding community partnership, genomics research and the board's work, he conducted open-ended interviews with six board members-an APOL-1-positive study patient, two community advocates, two physicians, and a leader of a network of neighborhood health centers participating in GUARDD-and transcribed and coded the interviews using constant comparative analysis. He shared the codes and associated quotations (made anonymous) with us, and we identified common themes of our responses, built a conceptual framework, and wrote the manuscript, for which we all chose to be co-authors. Here, we share themes related to community-based research around genomics and diverse populations.
"One Needs to be Vigilant": The Research Should Proceed, But Carefully
In the words of a local religious leader, "One needs to be vigilant when talking about medical dispositions that are asso- will be looking at them as individuals and not as a group."
Another echoed, "Now maybe White doctors won't view Black people on dialysis as not caring enough or not being compliant. They will recognize that there's more to sickness than bad behavior."
We also share a priority that Blacks understand the role of we are not the Ivory Tower."
In the words of a community physician, our goal is to "inform people without scaring them off." Recalling historical research abuses of Blacks, 13 it is crucial to ensure each participant's comfort and trust in the research process and understanding of genomics research. As a local religious leader said, "People shouldn't be signing [a consent form] because they are scared or embarrassed." As such, we worked closely with the institutional review board to remove "boilerplate" genomics language-which we found to be confusing and potentially alarming for participants-from consent forms. This is how people will become engaged: when someone who looks like them is at the helm." As this clinician concluded, "Precision medicine can't be about a subset of the population."
It is through bona fide collaborations like ours that may we begin to fill in the gaps.
CONCLUSIONS
Our partnership has embraced research on this complex intersection of race, ancestry, genomics and disparities to ensure the fair treatment and safeguard best interests of our communities. Our work as research-community liaisons established a bidirectional dialogue that makes GUARDD more than a research study; it is a longitudinal educational experience, a shared process that challenges and shapes Board members, researchers, clinicians and patients alike as it unfolds. We hope our experience highlights the need for such partnerships and ideas for fostering them. We encourage others to consider combining vigilance, flexibility, and clear communication from researchers with regular, respected, and incorporated community input to benefit health. Until such partnerships are the status quo, perhaps our manuscript-co-authored by a diverse array of community partners and researchers-may serve as a testament to their generative potential.
